Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surface modification for improved blood compatibility.

H Jacobs1, D Grainger, T Okano

  • 1Department of Pharmaceutics, University of Utah, Salt Lake City 84108.

Artificial Organs
|December 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.

Osteoarthritis and cartilage·2019
Same author

[Non-drug treatment of rheumatoid arthritis : An analysis of claims data and a survey of insured persons (Project PROCLAIR)].

Zeitschrift fur Rheumatologie·2018
Same author

[Toric intraocular lenses: a valuable method for correcting corneal astigmatism].

Klinische Monatsblatter fur Augenheilkunde·2015
Same author

Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission.

Translational psychiatry·2015
Same author

Differences in pharmacological activities of the antioxidant flavonoid monoHER in humans and mice are caused by variations in its metabolic profile.

Clinical pharmacology and therapeutics·2011
Same author

Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study.

Annals of the rheumatic diseases·2011
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

Surface modifications enhance blood-contacting device biocompatibility. Techniques like bioactive material immobilization and hydrophilic grafting reduce adverse biological reactions, improving device performance and patient outcomes.

Area of Science:

  • Biomaterials Science
  • Medical Device Engineering
  • Surface Chemistry

Background:

  • Blood-contacting devices require enhanced biocompatibility to minimize adverse biological responses.
  • Current limitations in device materials can lead to thrombus formation, platelet activation, and undesirable protein adsorption.
  • Improving surface properties is crucial for the safe and effective use of medical implants.

Purpose of the Study:

  • To review and summarize key surface modification techniques for improving blood-contacting device biocompatibility.
  • To highlight strategies for preventing thrombosis and platelet activation.
  • To discuss methods for reducing protein adsorption and regulating cell adhesion on device surfaces.

Main Methods:

  • Review of existing literature on surface modification techniques for biomedical applications.

Related Experiment Videos

  • Analysis of immobilization strategies for bioactive materials.
  • Examination of hydrophilic grafting onto hydrophobic polymer surfaces.
  • Exploration of microdomain-phase separated surfaces for controlled adhesion.

    • Main Results:

    • Immobilization of bioactive materials effectively prevents thrombus generation and platelet activation.
    • Incorporation of hydrophilic grafts onto hydrophobic surfaces (e.g., polyurethanes) significantly reduces protein adsorption.
    • Microdomain-phase separated surfaces offer a means to precisely regulate cellular and protein adhesion.

    Conclusions:

    • Surface modification is a critical strategy for enhancing the biocompatibility of blood-contacting devices.
    • Specific techniques, including bioactive material immobilization and hydrophilic grafting, offer targeted solutions to improve device performance.
    • Advanced surface designs, such as microdomain-phase separated surfaces, hold promise for future biocompatible materials.